Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China
- PMID: 19917382
- DOI: 10.1016/j.transproceed.2009.06.215
Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China
Abstract
Objective: We sought to review the etiopathogenesis, diagnosis, and surgical options for 253 patients with portal vein thrombosis (PVT) undergoing orthotopic liver transplantation (OLT) to assess the the impact of PVT on outcomes.
Methods: We retrospectively analyzed the data from 2508 adult patients undergoing 2614 OLTs in our center from September 1998 to July 2007. PVT was scored according to the operative findings and Yerdel grading of PVT. No prisoners were used as donors for this study.
Results: Two hundred fifty-three patients were diagnosed with PVT (10.09%): there were 104 grade I; 114, grade II; 29, grade III; and 6, grade IV PVT. Sex and previous splenectomy increased the risk for PVT. In grade I and II cases, we performed simple thrombectomy, eversion thrombectomy, or improved eversion thrombectomy (IET, innovated by our center), producing smooth postoperative recoveries with a 0% in-hospitality mortality. In grade III cases, 18 underwent successful IET. Of 11 subjects who had eversion thrombectomy, six failed, and the distal superior mesentery vein or dilated splanchnic collateral tributary had to be used as the inflow vessel in four patients, and portal vein arterialization were performed in the other two patients, all of whom experienced a smooth postoperative recovery except one who died of hepatic failure and pulmonary infection 2 weeks after the operation. The in-hospitality mortality was 3.45%. In grade IV cases, three underwent successful IET, but another three cases failed, with two of them requiring a renal vein as the inflow vessel, and other one undergoing portocaval hemitransposition, with one postoperative death due to hepatic failure and another of cancer recurrence, an in-hospitality mortality rate of 33.33%. The transfusion requirement among PVT patients was significantly higher than that in non-PVT patients (9.32 +/- 3.12 U vs 6.02 +/- 2.40 U; P < .01). Blood loss in PVT patients who underwent the IET technique was significantly lower than that for an eversion thrombectomy (2800.36 +/- 930.52 mL vs 5700.21 +/- 162.50 mL P < .05). The overall actuarial 1-year survival rate in PVT patients was similar to the controls (86.56% vs 89.40%; P > .05).
Conclusion: OLT was successfully performed for PVT patients. The grade of PVT decided the surgical strategy. Similar 1-year survival rates were attained between PVT patients and controls undergoing OLT.
Similar articles
-
Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome.Transplantation. 2000 May 15;69(9):1873-81. doi: 10.1097/00007890-200005150-00023. Transplantation. 2000. PMID: 10830225
-
Liver transplant recipients with portal vein thrombosis: a single center retrospective study.Hepatobiliary Pancreat Dis Int. 2009 Feb;8(1):34-9. Hepatobiliary Pancreat Dis Int. 2009. PMID: 19208512
-
Portal vein thrombosis and liver transplantation: long term.Transplant Proc. 2010 Mar;42(2):498-501. doi: 10.1016/j.transproceed.2010.01.038. Transplant Proc. 2010. PMID: 20304176
-
Surgical strategies for liver transplantation in the case of portal vein thrombosis--current role of cavoportal hemitransposition and renoportal anastomosis.Clin Transplant. 2006 Sep-Oct;20(5):551-62. doi: 10.1111/j.1399-0012.2006.00560.x. Clin Transplant. 2006. PMID: 16968480 Review.
-
Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up.Transplant Rev (Orlando). 2014 Apr;28(2):92-101. doi: 10.1016/j.trre.2014.01.003. Epub 2014 Jan 27. Transplant Rev (Orlando). 2014. PMID: 24582320 Review.
Cited by
-
Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: a scoping review.BMJ Open. 2019 Feb 5;9(2):e024473. doi: 10.1136/bmjopen-2018-024473. BMJ Open. 2019. PMID: 30723071 Free PMC article.
-
Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization.World J Gastroenterol. 2012 Jul 14;18(26):3443-50. doi: 10.3748/wjg.v18.i26.3443. World J Gastroenterol. 2012. PMID: 22807615 Free PMC article.
-
Portal vein surgical treatment on non-tumoral portal vein thrombosis in liver transplantation: Systematic Review and Meta-Analysis.Clinics (Sao Paulo). 2021 Jan 22;76:e2184. doi: 10.6061/clinics/2021/e2184. eCollection 2021. Clinics (Sao Paulo). 2021. PMID: 33503185 Free PMC article.
-
Prognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: a single-center experience from the People's Republic of China.Onco Targets Ther. 2014 Jun 9;7:957-64. doi: 10.2147/OTT.S64921. eCollection 2014. Onco Targets Ther. 2014. PMID: 24959082 Free PMC article.
-
Tailored classification of portal vein thrombosis for liver transplantation: Focus on strategies for portal vein inflow reconstruction.World J Gastroenterol. 2020 Jun 7;26(21):2691-2701. doi: 10.3748/wjg.v26.i21.2691. World J Gastroenterol. 2020. PMID: 32550747 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical